Dr. Giridhar Venkata Vedula, MD

Dr. Vedula practices at Piedmont Atlanta in Atlanta, Georgia, part of Piedmont Healthcare.

Dr. Vedula's NPI, 1730387697, was assigned on July 3, 2007. Dr. Vedula graduated from West Virginia University School Of Medicine in 2003. Dr. Vedula holds Georgia license 90758.

Dr. Vedula's primary practice is Piedmont Atlanta, at 1968 Peachtree Rd NW, Atlanta, GA 30309 in Fulton County. The practice phone is (404) 605-5000.

Dr. Vedula's primary practice is Piedmont Atlanta in Atlanta, Georgia, part of Piedmont Healthcare. The medical group on file is Piedmont Physicians Obstetrics and Gynecology of Jasper.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vedula practices. Vendor and product names are available with a free account.

Transplant surgery is Dr. Vedula's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Vedula is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Vedula's licenses on file in 7 states: Georgia, Colorado, Florida, Montana, New York, West Virginia and Washington.

Dmand AI lists gallbladder removal and kidney transplant among the conditions Dr. Vedula treats.

CMS data shows 19 Medicare services from Dr. Vedula across 1 procedure code in 2024, all of them office visits, for 37 Medicare patients. Medicare paid $1,329 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Dr. Vedula in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have high blood pressure, and 65% have chronic kidney disease. Their average risk score is 4.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vedula's median patient age at 57, with 50% women.

In 2024, Dr. Vedula wrote 55 Medicare Part D claims for 34 patients. 100% of them were for generic drugs. CMS names the drug for 22 of them, across 1 drug with 11 or more claims each, at $84 in total drug cost. In 2023, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Vedula for performance year 2024, reported through an alternative payment model (APM). Dr. Vedula accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Vedula, published from 2012 to 2013. The most frequent topics are Liver Transplantation. Dr. Vedula's most frequent co-authors are Benjamin Samstein, MD, Madison Colyn Cuffy, MD and Jean Crawford Emond, MD.

Dmand AI links Dr. Vedula to 1 clinical trial. Conditions studied include Liver Cirrhosis and Hepatitis C.

CMS Open Payments shows 49 general payments to Dr. Vedula from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Baxter Healthcare paid the most, $2,596.

Dmand AI lists 1 award for Dr. Vedula.

Dr. Vedula graduated from West Virginia University School Of Medicine in 2003. Dr. Vedula is a member of ACS.

Dr. Vedula is in network with 15 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Cigna. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.